Cargando…
Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination
KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID‐19 vaccination. Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34‐year‐old fe...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182003/ https://www.ncbi.nlm.nih.gov/pubmed/37192849 http://dx.doi.org/10.1002/ccr3.7342 |
_version_ | 1785041697237893120 |
---|---|
author | Teng, Hsiang‐Chiun Chen, Hsin‐Hsu |
author_facet | Teng, Hsiang‐Chiun Chen, Hsin‐Hsu |
author_sort | Teng, Hsiang‐Chiun |
collection | PubMed |
description | KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID‐19 vaccination. Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34‐year‐old female with no systemic illness presented with non‐scarring hair loss after the second COVID‐19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double‐spin PRP therapy. Her hair recovered completely after six courses of PRP treatment. |
format | Online Article Text |
id | pubmed-10182003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101820032023-05-14 Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination Teng, Hsiang‐Chiun Chen, Hsin‐Hsu Clin Case Rep Case Report KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID‐19 vaccination. Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34‐year‐old female with no systemic illness presented with non‐scarring hair loss after the second COVID‐19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double‐spin PRP therapy. Her hair recovered completely after six courses of PRP treatment. John Wiley and Sons Inc. 2023-05-12 /pmc/articles/PMC10182003/ /pubmed/37192849 http://dx.doi.org/10.1002/ccr3.7342 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Report Teng, Hsiang‐Chiun Chen, Hsin‐Hsu Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination |
title | Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination |
title_full | Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination |
title_fullStr | Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination |
title_full_unstemmed | Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination |
title_short | Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination |
title_sort | platelet‐rich plasma in the treatment of alopecia areata after covid‐19 vaccination |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182003/ https://www.ncbi.nlm.nih.gov/pubmed/37192849 http://dx.doi.org/10.1002/ccr3.7342 |
work_keys_str_mv | AT tenghsiangchiun plateletrichplasmainthetreatmentofalopeciaareataaftercovid19vaccination AT chenhsinhsu plateletrichplasmainthetreatmentofalopeciaareataaftercovid19vaccination |